Anetumab Ravtansine: A Novel Mesothelin-Targeting...

Molecular Cancer Therapeutics 2014 / 06 Vol. 13; Iss. 6

Anetumab Ravtansine: A Novel Mesothelin-Targeting Antibody-Drug Conjugate Cures Tumors with Heterogeneous Target Expression Favored by Bystander Effect

Golfier, S., Kopitz, C., Kahnert, A., Heisler, I., Schatz, C. A., Stelte-Ludwig, B., Mayer-Bartschmid, A., Unterschemmann, K., Bruder, S., Linden, L., Harrenga, A., Hauff, P., Scholle, F.-D., Muller-T
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-13-0926
Date:
June, 2014
File:
PDF, 2.21 MB
english, 2014
Conversion to is in progress
Conversion to is failed